LEUKEMIA, MYELOID, ACUTE
Clinical trials for LEUKEMIA, MYELOID, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia cases? trial tests DFP-10917 after multiple failures
Disease control TerminatedThis study tested a new drug called DFP-10917 in adults with acute myeloid leukemia (AML) that came back or didn't respond after 2 to 4 prior treatments. Participants received either DFP-10917 or one of several standard reinduction therapies. The goal was to see if DFP-10917 coul…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE3 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo trial for tough blood cancers ends early
Disease control TerminatedThis early-stage study tested a new drug called CC-95251, alone or with other cancer drugs, in people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that had come back or not responded to treatment. The main goals were to check safety and find the right dose…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:53 UTC